antiviral and associated therapy - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 severe or critically

	infections other than COVID-19
antiviral and associated therapy
chloroquine and derivatives	Paton Tricou Borges

15 studies excluded by filtering options 0

4909	Lee, 2004	0	1	0	selection pending
4910	Soo, 2004	0	0	0	selection pending
4911	HKU/UCH SARS Study Group, 2004	0	0	0	selection pending
4912	Chan, 2003	0	0	0	selection pending
4913	Beigel, 2018	0	1	0	selection pending
5300	Raquel, 2019	2	1	0	excluded		risk of bias not avaialble
5302	Peymani, 2016	1	1	3			high risk of bias
5303	Jacobson, 2016	2	1	0	excluded		risk of bias not avaialble
5307	CuraChik (De Lamballerie), 2008	1	1	3			high risk of bias
5308	Sperber, 1995	2	1	0	excluded		risk of bias not avaialble
5309	Paton, 2012	2	1	0	excluded		risk of bias not avaialble
5470	Singh, 2020	0	21	0	selection pending
5471	Sarayani, 2020	0	21	0	selection pending
5556	Coenen, 2020	0	0	0	selection pending
5681	Lane, 2020	0	13	0	selection pending